First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis
-
Published:2021-12
Issue:
Volume:
Page:
-
ISSN:0736-4679
-
Container-title:The Journal of Emergency Medicine
-
language:en
-
Short-container-title:The Journal of Emergency Medicine
Author:
Peacock W. FrankORCID,
Slatkin Neal E.,
Israel Robert J.,
Stambler Nancy
Funder
Boehringer Ingelheim
Abbott Laboratories
Roche
Subject
Emergency Medicine
Reference23 articles.
1. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1);Bell;Pain Med,2009
2. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation;Camilleri;Neurogastroenterol Motil,2014
3. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden;Panchal;Int J Clin Pract,2007
4. Opioid-induced constipation among patients with chronic noncancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time;Coyne;Pain Med,2015
5. Opioid-induced constipation: pathophysiology, clinical consequences, and management;Kumar;Gastroenterol Res Pract,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献